{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:04:24Z","timestamp":1780340664023,"version":"3.54.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.arcped.2021.03.002","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T16:01:15Z","timestamp":1618329675000},"page":"338-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tyrosinemia type 1 in pediatric nephrology: Not always straightforward"],"prefix":"10.1016","volume":"28","author":[{"given":"Sissa","family":"Brito dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lia","family":"Bertholet-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Butin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1656-1094","authenticated-orcid":false,"given":"Laurence","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fouilhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0578-2529","authenticated-orcid":false,"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2021.03.002_bib0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40272-019-00364-4","article-title":"Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1","volume":"21","author":"Van Ginkel","year":"2019","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.arcped.2021.03.002_bib0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pcl.2017.11.008","article-title":"Inborn Errors of Metabolism with Hepatopathy: Metabolism Defects of Galactose, Fructose, and Tyrosine","volume":"65","author":"Demirbas","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.arcped.2021.03.002_bib0075","first-page":"19","article-title":"Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations","author":"Chinsky","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.arcped.2021.03.002_bib0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymgme.2014.07.010","article-title":"Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs","volume":"113","author":"De Jes\u00fas","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.arcped.2021.03.002_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-8-8","article-title":"Recommendations for the management of tyrosinaemia type 1","volume":"11","author":"de Laet","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.arcped.2021.03.002_bib0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13023-017-0696-z","article-title":"Evaluation of pre-symptomatic nitisinone treatment on long-term outcomes in Tyrosinemia type 1 patients: a systematic review","volume":"12","author":"Geppert","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.arcped.2021.03.002_bib0095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10545-014-9683-x","article-title":"Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function","volume":"37","author":"Bartlett","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.arcped.2021.03.002_bib0100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10545-006-9994-7","article-title":"Renal function in tyrosinemia type I after liver transplantation: a long -term follow up","volume":"29","author":"Pierick","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.arcped.2021.03.002_bib0105","first-page":"308","article-title":"Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I)","volume":"47","author":"Tanguay","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcped.2021.03.002_bib0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.ki.5002113","article-title":"Renal histopathology of stone-forming patients with distal renal tubular acidosis","volume":"71","author":"Evan","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcped.2021.03.002_bib0115","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00467-012-2152-6","article-title":"Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria","volume":"27","author":"Menni","year":"2012","journal-title":"Pediatric Nephrol"},{"key":"10.1016\/j.arcped.2021.03.002_bib0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X21000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X21000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:53:50Z","timestamp":1760540030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X21000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0929693X21000464"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2021.03.002","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosinemia type 1 in pediatric nephrology: Not always straightforward","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2021.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}